chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: COVID 19; COVID 19; This is a spontaneous report received from a contactable reporter (Other HCP). The reporter is the patient. A 55-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 21Dec2022 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 46 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "HBP" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Tested positive again 12 days after starting paxlovid. Therapeutic measures were taken as a result of drug ineffective, covid-19 which included Paxlovid from 03Jul2023 to 05Aug2023. Additional information: the patient has no known allergies.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.; Sender's Comments: Based on available information, a lack of efficacy with the suspect vaccine BNT162B2 in this patient cannot be completely excluded.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Drug ineffective
Clinical narrative: Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  An 84-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), in Jun2023 as dose 6 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown), as dose 4 (booster), single (Batch/Lot number: unknown) and as dose 5 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Hypothyroid" (unspecified if ongoing); "known allergies: Xarelto" (unspecified if ongoing). There were no concomitant medications. No other medication in 2weeks. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19 which included Paxlovid from 02Aug2023 to 06Aug2023.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.; Sender's Comments: Based on available information, a lack of efficacy with the suspect vaccine BNT162B2 in this patient cannot be completely excluded.
Age: 55.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 56-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 28Sep2022 as dose 3 (booster), single (Lot number: GH9703) at the age of 55 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Negative; Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An 80-year-old male patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Negative, notes: Covid test was negative; Positive, notes: Two days later, it was positive again. Therapeutic measures included Paxlovid from 04Aug2023 to 09Aug2023 were taken as a result of drug ineffective, covid-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 45.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Drug ineffective
Clinical narrative: Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 46-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 04Oct2022 at 12:00 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 45 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "recovering" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19 with Paxlovid from 01Aug2023 to 05Aug2023. The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Sex: U
Vaccine: COVID19
Symptoms: Cerebrovascular accident, Hypertension
Clinical narrative: Stroke; Hypertension; This is a spontaneous report received from a contactable physician from medical information team, Program ID: (RA).  A 72-year-old patient received BNT162b2, BNT162b2 OMI BA.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), in Feb2023 as dose number unknown (booster), single (Batch/Lot number: unknown) for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: COVID-19 vaccine (Primary Immunization series complete; unknown manufacturer), for COVID-19 immunization. The following information was reported: HYPERTENSION (non-serious) with onset 2023, outcome "recovered" (2023); CEREBROVASCULAR ACCIDENT (medically significant) with onset 2023, outcome "recovered" (2023), described as "Stroke". The physician was calling about the Pfizer COVID-19 vaccine new variant or booster. The patient who had a stroke, hypertension, is high-risk he said but it is healthy now and had the last bivalent 6 months ago. The physician is further asking when it will be available so that his patients, specifically older people will be able to get it. doctor was asking for the availability status of the XBB variant for his older patients. They're about 10 to 20 patients. These patients will be traveling in Sep2023, and the physician would like to know if they should wait for the release of the XBB vaccine or get another Bivalent booster or just leave it like that.  The information on the batch/lot number for BNT162b2, BNT162b2 OMI BA.4-5 has been requested and will be submitted if and when received.; Sender's Comments: Based on available information, the event stroke is more likely related to the elderly patient's underlying medical conditions so that is not considered related to the suspect vaccine BNT162b2, BNT162b2 OMI BA.4-5. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate. This case will be reassessed once additional information is available.
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 72-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 26Sep2022 as dose 4 (booster), single (Lot number: gj3277) at the age of 71 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Treatment of COVID-19; Negative. Therapeutic measures were taken as a result of drug ineffective, covid-19.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 67-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 21Nov2022 as dose 5 (booster), single (Lot number: GL0446) at the age of 66 years, in left arm for COVID-19 immunisation; COVID-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for COVID-19 immunisation. The patient's relevant medical history included: "HTN" (unspecified if ongoing); "OSA" (unspecified if ongoing); "Known allergies: Sulfa drugs" (unspecified if ongoing); "Known allergies: PCN" (unspecified if ongoing). The patient's concomitant medications were not reported.  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, COVID-19.; Sender's Comments: Based on available information, a lack of efficacy with the suspect vaccine BNT162B2 in this patient cannot be completely excluded.
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: 7 people had died from Pfizer; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP), Program ID.  A male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DEATH (death), outcome "fatal", described as "7 people had died from Pfizer". The date and cause of death for the patient were unknown. It was not reported if an autopsy was performed. Clinical course: Age + years/months/days: 50-99. Age Group: Elderly (greater than equal to 65 years). Moderna has proven to be effective against COVID-19; Pfizer is not that effective when the reporter first heard about it. 7 people had died from Pfizer; So that made a change in mind about taking Moderna. Plus, the Primary Care doctor suggested Moderna based of these stories that the reporter heard. The reporter considers the event as caused by the suspect product.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202300139954 Same reporter/event/drug, different patient;; Reported Cause(s) of Death: 7 people had died from Pfizer
Sex: U
Vaccine: PNC20
Symptoms: Syringe issue
Clinical narrative: the needle assembly broke off at the hub (the glass area broke); This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group.  A patient (no qualifiers provided) received pneumococcal 20-val conj vac (dipht CRM197 protein) (PREVNAR 20), as dose number unknown, single (Lot number: GT6700) for immunisation, Device Lot Number: GT6700. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DEVICE BREAKAGE (non-serious), outcome "unknown", described as "the needle assembly broke off at the hub (the glass area broke)".  Additional information: The nurse was closing the safety device on a Prevnar 20 PFS. The needle assembly broke off at the hub (the glass area broke). They will have the nurses check for defects in the others before using. She was not injured but reporter can see where this may occur.
Sex: F
Vaccine: COVID19, FLUX
Symptoms: Illness
Clinical narrative: got very sick; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP), Program ID. The reporter is the patient.  An elderly female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; influenza vaccine (FLU [INFLUENZA VACCINE]), as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer), for COVID-19 immunization; Covid-19 vaccine (DOSE NUMBER UNKNOWN (BOOSTER), SINGLE; unknown manufacturer), for COVID-19 immunization. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "got very sick".  Additional information: The patient had Pfizer as her 2nd booster with the flu shot and got very sick. The reporter considered event as caused by suspect product.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: slight fever; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP), Program ID: (RA).  A 76-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PYREXIA (non-serious), outcome "unknown", described as "slight fever".  Additional information: the reporter's brother had Pfizer and had a slight fever. The reporter considered the event as caused by suspect product.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Respiratory tract malformation
Clinical narrative: born with several airway birth defects and almost died; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP), Program ID: (RA). The reporter is the parent.  A neonate male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown, single (Batch/Lot number: unknown) for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: RESPIRATORY TRACT MALFORMATION (congenital anomaly, life threatening), outcome "unknown", described as "born with several airway birth defects and almost died". The father reported that his son was born with several airway birth defects and almost died.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Eye pain
Clinical narrative: eye pain; This is a spontaneous report received from a contactable reporter (other HCP), Program ID. The reporter is the patient. A 35-year-old female patient received BNT162b2 (PFIZER BIONTECH COVID-19 VACCINE), on 17Dec2020 as dose 1, single (lot number EK5730) at the age of 35 years intramuscular, in arm for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: EYE PAIN (non-serious), outcome "unknown".; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202200014413 same patient/product, different vaccine dose/event;
Sex: F
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: Sick; This is a spontaneous report received from a non-contactable consumer, Program ID: (RA).  An elderly female patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ILLNESS (non-serious), outcome "recovered", described as "Sick".  Additional Information: The patient got Pfizer COVID-19 vaccine one day and was sick for a week. The patient's friend considered that the event was caused by the suspect product.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 7.0
Sex: M
Vaccine: IPV
Symptoms: Poor quality product administered, Product storage error
Clinical narrative: due to multiple reasons (sometimes refrigerator was left opened, maintenance and cleaning, power outage) temp reached was 32.5f;temp: 35fduration: 356 minutes or around 6 hours with no reported adverse event; ipol that after a series of excursions. ipol was opened and administered with no reported adverse event; Initial information received on 10-Aug-2023 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves temperature excursion, due to multiple reasons (sometimes refrigerator was left opened, maintenance and cleaning, power outage) temp reached was 32.5 f;temp: 35f duration: 356 minutes or around 6 hours and IPV (VERO) [IPOL] that after a series of excursions. IPOL was opened and administered to a 7 years old male patient with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, due to multiple reasons (sometimes refrigerator was left opened, maintenance and cleaning, power outage) temp reached was 32.5f;temp: 35fduration: 356 minutes or around 6 hours with no reported adverse event (product storage error) (unknown latency).  On 24-Jul-2023, the patient received a dose of 0.5 ml 1x (Frequency = once) dose 4 of suspect IPV (VERO) of standard strength suspension for injection (lot: W1A191M, Expiry date: 16-Feb-2025) via intramuscular route in the right thigh for Immunization, that after a series of excursions. IPOL was opened and administered with no reported adverse event (poor quality product administered) (latency: same day).  Action taken: not applicable.  At time of reporting, the outcome was Unknown for both the events.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray abnormal, Cough, Hypophagia, Malaise
Clinical narrative: Presented with syncopal episode after falling ill with malaise; he developed cough and had poor oral intake and experienced a syncopal event and came into the ED where he tested positive for COVID. Chest Xray showed an possible infiltrate on the left side, he did not require supplemental O2.  Tx w/abx, Remdesivir, Vit D3, Vit C, zinc; dc'd home.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Syncope
Clinical narrative: Presented with syncopal episode after falling ill with malaise; he developed cough and had poor oral intake and experienced a syncopal event and came into the ED where he tested positive for COVID. Chest Xray showed an possible infiltrate on the left side, he did not require supplemental O2.  Tx w/abx, Remdesivir, Vit D3, Vit C, zinc; dc'd home.
Age: 94.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray abnormal, Computerised tomogram head, Computerised tomogram spine normal, Fall
Clinical narrative: Pt presented to ED s/p ground level fall slipping out of his wheelchair falling to the ground.  Workup in ED included CT of the head and CT of the cervical spine that was negative for acute pathology.  Chest x-ray showed coarse bilateral interstitial opacities; pt tested positive for COVID-19. Tx w/O2, abx, remdesivir, steroids, Vit C, zinc.  Dc'd back to assisted living w/HHC.
Age: 94.0
Sex: M
Vaccine: COVID19
Symptoms: Lung opacity, SARS-CoV-2 test positive
Clinical narrative: Pt presented to ED s/p ground level fall slipping out of his wheelchair falling to the ground.  Workup in ED included CT of the head and CT of the cervical spine that was negative for acute pathology.  Chest x-ray showed coarse bilateral interstitial opacities; pt tested positive for COVID-19. Tx w/O2, abx, remdesivir, steroids, Vit C, zinc.  Dc'd back to assisted living w/HHC.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Headache, Hypoxia, Influenza like illness, Malaise
Clinical narrative: Pt c/o flu like symptoms- subjective fevers, malaise with body aches and headache started yesterday associated with nausea and non bloody and nonb ilious vomiting so came to ER. On arrival pt found to have hypoxic dx w/ COVID-19 pna; tx w/ O2, steroids, zinc, abx; weaned to RA for home dc.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Pain, Pyrexia, Vomiting
Clinical narrative: Pt c/o flu like symptoms- subjective fevers, malaise with body aches and headache started yesterday associated with nausea and non bloody and nonb ilious vomiting so came to ER. On arrival pt found to have hypoxic dx w/ COVID-19 pna; tx w/ O2, steroids, zinc, abx; weaned to RA for home dc.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Groin infection, SARS-CoV-2 test positive
Clinical narrative: Admitted and started on antibiotics for left groin infection; COVID-19+, tx w/remdesivir, O2, steroids, abx; weaned to RA for dc home.
Age: 11.0
Sex: M
Vaccine: COVID19-2, HPV9, MNQ, TDAP
Symptoms: Unevaluable event
Clinical narrative: NONE
Age: 36.0
Sex: M
Vaccine: COVID19-2
Symptoms: Asthenia, COVID-19 pneumonia, Urinary retention
Clinical narrative: Hospitalized.  Generalized weakness, urinary retention, and COVID pneumonia.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Hypoxia
Clinical narrative: Admitted here for COVID-19 pneumonia and hypoxemia; tx w/O2, Vit C, steroids, & zinc; weaned to RA; dc'd home
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Pyrexia
Clinical narrative: Presented with COVID initially diagnosed 12/31; saw a telemed doctor on 1/1 and was precribed 5 days of prednisone 60 mg daily which he finished the day prior to admission.  He states symptoms initially improved then worsened again the last few days.  His oxygen remained in low 90s.  He has been ambulatory around the house.  He presented due to fever at home. Due to persistent, progressive sx's, patient was admitted and placed on decadron and oxygen. Weaned to RA for dc home.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Diarrhoea, Malaise, SARS-CoV-2 test positive
Clinical narrative: Presented to ED w/ generalized weakness, diarrhea, and overall sense of not feeling well; patient was noted to be positive for COVID-19; tx with abx, remdesivir, O2.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19 pneumonia
Clinical narrative: Admitted for pneumonia due to COVID-19; tx w/steroids, singulair, zinc, abx, O2. Weaned to RA for dc home
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, SARS-CoV-2 test positive
Clinical narrative: Presented from home via EMS after family noted patient has been increasingly weak.  Patient was tested positive for COVID 19; tx w/abx, O2, steroids, Vit C, zinc; dc home w/hhc & O2.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Back pain, COVID-19 pneumonia, Pain
Clinical narrative: Presented with lower back pain that radiated to abdomen; dx w/COVID-19 pna; tx w/abx, steroids, zinc, O2. Weaned to RA, dc'd home.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19
Clinical narrative: Admitted for acute hypoxic respiratory failure: due to covid-19; tx w/steroids, remdesivir, singulair, zinc, O2. Dc'd to LTAC w/O2
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Bronchitis, COVID-19, Pulmonary embolism
Clinical narrative: Hospitalization for acute right-sided pulmonary embolisum, COVID-19, acute bronchitis on dates 7/26/2023-7/31/2023. Treated with methylprednisolone, baricitinib, Remdesivir, vitamin C 1,000 mg PO daily, vitamin D 25 mcg PO daily, zinc 50 mg PO daily.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough
Clinical narrative: Admitted with cough; COVID-19 no pna; tx w/steroids, redemsivir, Vit C, zinc, O2; weaned to RA, discharged home.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, COVID-19 pneumonia, Intensive care, PCO2 increased
Clinical narrative: Arrived to the emergency department via EMS and was in respiratory distress, initial ABG showed a pCO2 of 88, admitted to the ICU for acute hypoxemic respiratory failure, found to have COVID-19 and COVID pneumonia. Tx w/remdesivir, abx, steroids, O2, zinc. Discharged to SNF on O2.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory distress
Clinical narrative: Arrived to the emergency department via EMS and was in respiratory distress, initial ABG showed a pCO2 of 88, admitted to the ICU for acute hypoxemic respiratory failure, found to have COVID-19 and COVID pneumonia. Tx w/remdesivir, abx, steroids, O2, zinc. Discharged to SNF on O2.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Atypical pneumonia, COVID-19 pneumonia, Pneumonia
Clinical narrative: Admitted for bilateral atypical pneumonia with acute hypoxic respiratory failure secondary to COVID-19 pneumonia; tx w/remdesivir, O2, steroids, abx, zinc; weaned to RA for dc home.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Diarrhoea, SARS-CoV-2 test positive
Clinical narrative: Presented with diarrhea and generalized weakness. Tested positive for COVID-19. tx w/abx & steroids; did not require O2; DC to SNF
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Fall, SARS-CoV-2 test positive
Clinical narrative: Presented w chief c/o fall, O2 dependent d/t chronic resp failure; COVID-19+; tx w/remdesivir, abx, steroids, zinc, O2; dc to SNF.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Pneumonia, Sepsis
Clinical narrative: Hospitalization for Sepsis due to left lower lobe pneumonia on dates 7/29/2023-7/31/2023. Treated with dexamethasone, baricitinib, Remdesivir, vitamin C 1,000 mg PO daily, vitamin D 25 mcg PO daily, zinc 50 mg PO daily.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Death, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: Presented with complaints of progressively worsening shortness of breath.  Patient was recently diagnosed with COVID-19 3 days prior to the admission. COVID-19+ pna; tx w/abx, steroids, O2, zinc; pt did not improve w/ tx; pt made DNR followed by comfort care & subsequently expired.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Haemoptysis, Pyrexia
Clinical narrative: Presented to the ED c/o hemoptysis onset last night with associated fever. Dx COVID-19 pna; tx w/remdesivir, abx, Vit C, zinc; did not require O2; dc'd home
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Pneumonia
Clinical narrative: Presented w/ chest pain probably secondary to Coreg 19 pneumonia; tx w/VitC, steroids, zinc; no O2 required; returned to rehab
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Pneumonia, SARS-CoV-2 test positive, Sepsis, Urinary tract infection
Clinical narrative: Hospitalization for Sepsis due to UTI/Pneumonia, COVID positive on dates 7/28/2023-8/2/2023. Treated with dexamethasone, baricitinib, Remdesivir, vitamin C 1,000 mg PO daily, vitamin D 25 mcg PO daily, zinc 50 mg PO daily.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Bradycardia, COVID-19, Hypotension, Syncope
Clinical narrative: Hospitalization for syncope, COVID-19, bradycardia and hypotension on dates 7/30/2023-8/2/2023. Treated with dexamethasone, baricitinib, Remdesivir, vitamin C 1,000 mg PO daily, vitamin D 25 mcg PO daily, zinc 50 mg PO daily.
Age: 12.0
Sex: F
Vaccine: DTAP
Symptoms: Inappropriate schedule of product administration, Wrong product administered
Clinical narrative: on 8/11/23 I have given the patient the wrong vaccine at 12:42. I overlooked the immunization sheet and have given vaccine sooner than the recommend date.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Diarrhoea, Dyspnoea, Malaise, Nausea
Clinical narrative: Chief Complaint: Covid like Symptoms.  Pt complains of vomiting, nausea, diarrhea, mild cough, SOB, rhinorrhea and fever.Treated with IV antibiotics, remdesivir, steroids vit c, vit d, zinc OptiFlow.  home with oxygen
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rhinorrhoea, Vomiting
Clinical narrative: Chief Complaint: Covid like Symptoms.  Pt complains of vomiting, nausea, diarrhea, mild cough, SOB, rhinorrhea and fever.Treated with IV antibiotics, remdesivir, steroids vit c, vit d, zinc OptiFlow.  home with oxygen
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Chest tube insertion, Hypoxia, Malaise, Pyrexia
Clinical narrative: Chief Complaint: Covid Like Symptoms (hypoxia, fever, weakness)taking steroids and singular at home .Tx. oral steroids Chest tube thoracostomy intravenous Decadron, high-flow supplemental oxygen up to 60.  Discharge Condition: Improved and Still profoundly ill.  discharged to long term acute
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Atrial flutter, Echocardiogram, Electrocardiogram, Electrocardiogram ambulatory, Fatigue
Clinical narrative: SVT, atrial flutter, fever, fatigue, headache
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Headache, Pyrexia, Supraventricular tachycardia
Clinical narrative: SVT, atrial flutter, fever, fatigue, headache
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Cerebrovascular accident, Cough, Death, Dyspnoea
Clinical narrative: Chief Complaint: Stroke Symptoms or Stroke Alert Difficulty moving left upper extremity, cough, shortness of breath, without wheezing .  Sepsis due to pneumonia from COVID-19.  Cause of death - Acute CVA and multifocal pneumonia due to COVID pneumonia
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Mobility decreased, Sepsis
Clinical narrative: Chief Complaint: Stroke Symptoms or Stroke Alert Difficulty moving left upper extremity, cough, shortness of breath, without wheezing .  Sepsis due to pneumonia from COVID-19.  Cause of death - Acute CVA and multifocal pneumonia due to COVID pneumonia
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Heart rate increased
Clinical narrative: Presented to the Emergency Department for shortness of breath with rapid heart rate.  azithromycin/ceftriaxone.   --Decadron --vitamin-C/zinc                                                                                                                                              3-4 L of supplemental oxygen via nasal cannula
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Chest pain, Dyspnoea
Clinical narrative: Presents to the ED due to chest pain with associated SOB and increased work of breathing.   Pneumonia due to COVID-19 virus. Steroids,completed Remdesivir D5/5.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: Chief Complaint: SOB.  Tested positive for COVID.  Decadron Remdesivir .    Death due to Covid 19
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, SARS-CoV-2 test positive
Clinical narrative: Chief Complaint: generalized weakness.  Pt is COVID positive . Pt was COVID vaccinated without the booster.  on Remdesvir
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Cough, Electrocardiogram abnormal, Pain
Clinical narrative: Presented w/ body ache, weakness, cough, congestion. Dx Covid+ by PCP. Tx for pneumonia w/ abx, admitted d/t elevated troponin, EKG changes. Dexamethasone
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Pneumonia, Respiratory tract congestion, SARS-CoV-2 test positive, Troponin increased
Clinical narrative: Presented w/ body ache, weakness, cough, congestion. Dx Covid+ by PCP. Tx for pneumonia w/ abx, admitted d/t elevated troponin, EKG changes. Dexamethasone
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19 pneumonia, Cough, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: Presented w/ SOB, cough, weakness X1 wk. Tx for covid+ pneumonia w/ Dexamethasone, Zinc, IV, Remdesivir, O2
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Tremor
Clinical narrative: Presented via EMS w/ tremors, onset 2 hrs prior. Incidently, Covid+ but asymptomatic. Did get Remdesivir on day 3.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19 pneumonia, Nausea, SARS-CoV-2 test positive, Vomiting
Clinical narrative: Presented w/ n/v X3 days, tx w/ IVF and hospitalization complicated by Covid+ pneumonia w/ acute hypoxic resp. failure. Tx w/ O2, Dexamethasone, Remdesivir
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain lower, Arthralgia, Asthenia, COVID-19, Cough
Clinical narrative: Presented via EMS w/ weakness, AMS and rt. hip pain, RLQ pain, cough & fever. Hypoxic to 74% w/ strong odor to urine upon arriving. Covid+, symptomatic. Tx w/ O2, Vit C, zinc, abx, Remdesivir, steroids
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoxia, Mental status changes, Pyrexia, SARS-CoV-2 test positive, Urine odour abnormal
Clinical narrative: Presented via EMS w/ weakness, AMS and rt. hip pain, RLQ pain, cough & fever. Hypoxic to 74% w/ strong odor to urine upon arriving. Covid+, symptomatic. Tx w/ O2, Vit C, zinc, abx, Remdesivir, steroids
Age: 12.0
Sex: F
Vaccine: MENB
Symptoms: Wrong product administered
Clinical narrative: DR order the wrong vaccine and she called and talk to (Mother) of patient.
Sex: M
Vaccine: DTPPVHBHPB, PNC13, RV5, DTPPVHBHPB, PNC13, RV5
Symptoms: Death
Clinical narrative: Patient went to bed in his normal state of health the night he received his vaccine and was found deceased upon family waking the following morning
Age: 62.0
Sex: M
Vaccine: VARZOS
Symptoms: Seizure
Clinical narrative: Patient had 2 seizures 1 minute after vaccine administration
Age: 15.0
Sex: F
Vaccine: MNQ
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Pt received Menactra prior to 16th birthday.
Age: 1.0
Sex: F
Vaccine: HEPA, HIBV, PNC13
Symptoms: Pyrexia
Clinical narrative: Fever of 103
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Coagulopathy, Rectal haemorrhage, Type 2 diabetes mellitus, Type V hyperlipidaemia
Clinical narrative: D68.9 COAGULOPATHY, UNSPECIFIED TYPE 4/24/2023 RECTAL BLEEDING D68.9 COAGULOPATHY, UNSPECIFIED TYPE 4/24/2023 DM 2 W MIXED HYPERLIPIDEMIA
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Balance disorder, COVID-19, Dysstasia, Exposure to SARS-CoV-2
Clinical narrative: Presented w/ increased generalized weakness and urinary incontinence.  He has not been able to stand or ambulate today. She also noted he has increased balance problems and fell last week.  He was exposed to Covid 19 last week through a family member; tested positive for COVID-19; dx w/pna; tx w/abx, Vit C/D, zinc, steroids, remdesivir, did not require O2.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Fall, Gait inability, Pneumonia, SARS-CoV-2 test positive, Urinary incontinence
Clinical narrative: Presented w/ increased generalized weakness and urinary incontinence.  He has not been able to stand or ambulate today. She also noted he has increased balance problems and fell last week.  He was exposed to Covid 19 last week through a family member; tested positive for COVID-19; dx w/pna; tx w/abx, Vit C/D, zinc, steroids, remdesivir, did not require O2.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Arteriosclerosis coronary artery
Clinical narrative: ACUTE ST ELEVATION MI, UNSPECIFIED 3/17/2023 ASHD NATIVE CORONARY ARTERY W/O ANGINA PECTORIS
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Chronic kidney disease, Diabetic nephropathy, Glomerular filtration rate, Hypercholesterolaemia, Hypotension
Clinical narrative: HYPOTENSION 5/4/2023 DM 2 W RENAL MANIFESTATION HYPOTENSION 5/4/2023 CKD STAGE 3A (GFR 45-59) HYPOTENSION 5/4/2023 HYPERCHOLESTEROLEMIA HYPOTENSION 5/4/2023 SYNCOPE AND COLLAPSE
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Syncope
Clinical narrative: HYPOTENSION 5/4/2023 DM 2 W RENAL MANIFESTATION HYPOTENSION 5/4/2023 CKD STAGE 3A (GFR 45-59) HYPOTENSION 5/4/2023 HYPERCHOLESTEROLEMIA HYPOTENSION 5/4/2023 SYNCOPE AND COLLAPSE
Age: 39.0
Sex: M
Vaccine: TDAP
Symptoms: Product storage error
Clinical narrative: Planned power outage occurred on Saturday, 8/12 from 12:00p-11:00p. Asked facilities if medications from refrigerators in medication room needed to be removed due to power outages on 8/10/23. Was informed that medication room items should be on backup power so our refrigerator/freezers should be okay. Did not move medications out of these areas. Prior to being notified that refrigerators were out of range over weekend, patient was given adacel vaccine at visit today 8/14/23. Vaccine was given appropriately but should not have been given due to range of medication being inappropriate. Staff was not aware of refrigerator issue at time medication was given to patient. Management informed after of the temperature values in the area and placed signage in area to not use. Met with pharmacy and facilities and was told to discard all medications due to range values.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Chronic respiratory failure, Hypoxia, Pulmonary embolism, Respiratory failure
Clinical narrative: ACUTE PULMONARY EMBOLISM 4/21/2023 ACUTE PULMONARY EMBOLISM CHRONIC HYPOXEMIC RESPIRATORY FAILURE 4/24/2023 ACUTE PULMONARY EMBOLISM HYPOXIA 4/21/2023 ACUTE PULMONARY EMBOLISM ACUTE PULMONARY EMBOLISM 4/21/2023 HYPOXIA CHRONIC HYPOXEMIC RESPIRATORY FAILURE 4/24/2023 HYPOXIA HYPOXIA 4/21/2023 HYPOXIA
Age: 61.0
Sex: M
Vaccine: COVID19-2
Symptoms: Arthralgia
Clinical narrative: patient called on 8/14/23 and stated he was having problems with his left arm since the vaccine in 1/2023. states that his shoulder has hurt him off and on since the vaccine administered on 1/27/23. This was the first call of complaint.
Age: 0.5
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: Expired product administered
Clinical narrative: After administration of all vaccines and patient exit, this RN began to document them in the medical record when she noticed the expiration date for the ActHib was 8/11/23, which was 3 days prior. This RN contacted State Health Department  who was made aware of the situation. It was decided to give patient's third dose of ActHib at his 15 month visit. This RN contacted patient's Mother and explained exactly what happened and shared many apologies. She voiced her understanding, stated she was not upset as long as she knows patient is going to be ok, which he is.  No adverse reaction to patient noted at any time and Mom says patient is acting his normal self. She agreed to get third HIB at 15 month visit and thanked this RN for calling and being honest.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Epistaxis, Fibrin D dimer increased
Clinical narrative: Patient developed  abnormal/ elevated D-Dimer after booster shot with Pfizer vaccine  . After having overnight ( while sleeping ) nose bleeds, the patient went to the doctor and the D-dimer was 5 times above the normal limit.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Cardiac failure congestive, Myocardial ischaemia, Neuropathy peripheral
Clinical narrative: G62.9 PERIPHERAL NEUROPATHY 3/27/2023 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED I24.8 DEMAND ISCHEMIA 3/27/2023 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Ischaemic stroke
Clinical narrative: I63.9 ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 4/10/2023 ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Cerebrovascular accident, Lacunar stroke, Vision blurred
Clinical narrative: ACUTE LACUNAR STROKE, UNSPECIFIED TYPE AND ARTERY 4/13/2023 BLURRED VISION ACUTE STROKE, UNSPECIFIED TYPE AND ARTERY 4/12/2023 BLURRED VISION ACUTE LACUNAR STROKE, UNSPECIFIED TYPE AND ARTERY 4/13/2023 WEAKNESS ACUTE STROKE, UNSPECIFIED TYPE AND ARTERY 4/12/2023 WEAKNESS
Age: 0.58
Sex: M
Vaccine: DTAPHEPBIP, HEP, PNC13
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Patient was accidentally given two doses of Hepatitis B vaccine on 8/10/23 (Pediarix and HepB). On 8/14/23, mom stated pt had no concernings symptoms or atypical behavior after receiving vaccines and was doing well.
Age: 16.0
Sex: F
Vaccine: MNQ
Symptoms: Back pain, Chest pain, Dizziness, Malaise, Nausea
Clinical narrative: Mom reports when pt. got home from her appointment she complained of left sided chest pain radiating to her back. She woke up this morning not feeling well but went to school. She went to the school based health center around 8:30 due to nausea and dizziness. Mom plans to see MD today and will notify me of the results of that visit.
Age: 16.0
Sex: F
Vaccine: MNQ
Symptoms: Pain
Clinical narrative: Mom reports when pt. got home from her appointment she complained of left sided chest pain radiating to her back. She woke up this morning not feeling well but went to school. She went to the school based health center around 8:30 due to nausea and dizziness. Mom plans to see MD today and will notify me of the results of that visit.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Biopsy skin normal, Blister, Erythema, Pruritus, Sleep disorder
Clinical narrative: Several months after booster started getting itchy blisters on arms, torso, head and neck.  Start out as red and than blister.  Extremely itchy.  Has been ongoing since early 2022 with no relief.  Patient is up all night itching.  The only relief is when she is on prednisone.  Have tried topical ointments and nothing helps.  When one breakout ends, another starts immediately..
Age: 13.0
Sex: M
Vaccine: TD, TDAP
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: PATIENT WAS GIVEN TDAP AND TD GIVEN ON THE SAME DAY. NO MANIFESTIONS OF AN ADVERSE REACTION PRESENT. PT DENIED PAIN OR DISCOMFORT TO INJECTION SITE.
Age: 16.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Hyperhidrosis, Seizure
Clinical narrative: vaccines completed at 1225. Approx 1230, mother yelled and pt witnessing having seizure activity resembling a grand mal seizure. Seizure activity lasted approx 7-8 seconds. Pt was not incontinent. Pt diaphoretic. Pt looked over at mother post activity and asked what happened. Pt stated she felt like she had been in a long dream. vitals taken several times and stable.  Pt sees neuro for seizure activity--mother states she has frequent focal seizures but has not had grand mal activity for several /years. Called and talked to mother on  08/15/2023 and she stated pt has had zero seizure activity since and is awaiting guidance from neuro doctor of plan of care.
Age: 37.0
Sex: F
Vaccine: COVID19-2
Symptoms: Ear pain, Headache, Pain, Pain in extremity
Clinical narrative: Along with body aches, headache, and a sore left arm the next morning, there was also left ear pain. The patient has been taking Advil since that morning.
Age: 0.42
Sex: M
Vaccine: DTAPIPV, HIBV, PNC13
Symptoms: Hyperhidrosis, Malaise, Product administered to patient of inappropriate age, Pyrexia, Wrong product administered
Clinical narrative: Mother states that he got his vaccine and they informed him that he might get a fever.  He got really sweaty, it was an extreme fever to her.  She did not take him into the doctor as it was his first vaccines, and she felt it was normal.  He was sick for a few days.  She was contacted this past Thursday that he was given a 4-6 year vaccine instead of a 4 month old vaccine.  She was informed to keep an eye on him, and that he was now "super protected".    He has not had any other problems other than the initial reaction after the vaccine.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity
Clinical narrative: ALLERGIC REACTION, SUBSEQ ALLERGIC REACTION, SEQUELA
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Hypoxia
Clinical narrative: ACUTE NON ST ELEVATION MI HYPOXIA
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Angina pectoris
Clinical narrative: STABLE ANGINA
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMRV
Symptoms: Cough, Hypoxia, Lip swelling, Respiratory distress, Skin lesion
Clinical narrative: Within 5 minutes of vaccination, patient developed cough and vomiting. He was brought back to a patient room where widespread urticarial lesions developed on his face, trunk and extremities.  He was placed on oxygen 10Lpm rebreather mask due to respiratory distress and hypoxemia (pulse ox 83%), epinephrine 0.15 mg IM administered, EMS was called, diffuse wheezing noted on exam, oral benadryl administered, diffuse erythema of skin was noted and swelling of bottom lip, a second dose of epi 0.15mg was administered.  EMS arrived and patient was taken to the Emergency Department for further management.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMRV
Symptoms: Urticaria, Vomiting
Clinical narrative: Within 5 minutes of vaccination, patient developed cough and vomiting. He was brought back to a patient room where widespread urticarial lesions developed on his face, trunk and extremities.  He was placed on oxygen 10Lpm rebreather mask due to respiratory distress and hypoxemia (pulse ox 83%), epinephrine 0.15 mg IM administered, EMS was called, diffuse wheezing noted on exam, oral benadryl administered, diffuse erythema of skin was noted and swelling of bottom lip, a second dose of epi 0.15mg was administered.  EMS arrived and patient was taken to the Emergency Department for further management.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Behaviour disorder, Dementia, Epilepsy
Clinical narrative: DEMENTIA, UNSPECIFIED SEVERITY, DUE TO EPILEPSY W OTHER BEHAVIORAL DISTURBANCE
Age: 45.0
Sex: F
Vaccine: MMR
Symptoms: Guillain-Barre syndrome, Lumbar puncture
Clinical narrative: Guillian Barre